Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic "hot spots" for differentially expressed genes

Genomics
Alvin B CodaAnimesh A Sinha

Abstract

There are major gaps in our knowledge regarding the exact mechanisms and genetic basis of psoriasis. To investigate the pathogenesis of psoriasis, gene expression in 10 skin (5 lesional, 5 nonlesional) and 11 blood (6 psoriatic, 5 nonpsoriatic) samples were examined using Affymetrix HG-U95A microarrays. We detected 535 (425 upregulated, 110 downregulated) DEGs in lesional skin at 1% false discovery rate (FDR). Combining nine microarray studies comparing lesional and nonlesional psoriatic skin, 34.5% of dysregulated genes were overlapped in multiple studies. We further identified 20 skin and 2 blood associated transcriptional "hot spots" at specified genomic locations. At 5% FDR, 11.8% skin and 10.4% blood DEGs in our study mapped to one of the 12 PSORS loci. DEGs that overlap with PSORS loci may offer prioritized targets for downstream genetic fine mapping studies. Novel DEG "hot spots" may provide new targets for defining susceptibility loci in future studies.

References

Nov 1, 1978·The British Journal of Dermatology·C J McDonald, P Calabresi
Sep 15, 1998·Human Molecular Genetics·J Bhalerao, A M Bowcock
May 11, 1999·European Journal of Human Genetics : EJHG·C EnerbäckT Martinsson
Mar 26, 2002·The Pharmacogenomics Journal·J L OestreicherW L Trepicchio
Feb 14, 2004·The Journal of Investigative Dermatology·John FoersterGerard te Meerman
Mar 25, 2005·The British Journal of Dermatology·V Quekenborn-TrinquetC E M Griffiths
Nov 12, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jerzy K KulskiHidetoshi Inoko
Apr 28, 2006·American Journal of Human Genetics·Rajan P NairJames T Elder
Jul 22, 2006·The Journal of Investigative Dermatology·Joachim ReischlJürgen F Heubach
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Joel M GelfandAndrea B Troxel
Jun 21, 2007·The British Journal of Dermatology·P C M van de Kerkhof
Mar 28, 2008·Human Molecular Genetics·Francesca CaponRichard C Trembath
May 20, 2008·Seminars in Cutaneous Medicine and Surgery·Manfred Kunz
Jul 7, 2009·Free Radical Biology & Medicine·Qiang ZhouMartin Rostami-Yazdi
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Aug 18, 2009·The British Journal of Dermatology·R Van HarenA A Sinha
Oct 9, 2009·The Journal of Investigative Dermatology·James T ElderRajan P Nair
Oct 1, 2008·Circulation. Cardiovascular Genetics·James A WingroveWilliam E Kraus
Mar 12, 2010·The Journal of Investigative Dermatology·Johann E GudjonssonJames T Elder
Aug 19, 2011·The Journal of Investigative Dermatology·Ali JabbariJames G Krueger

❮ Previous
Next ❯

Citations

Oct 20, 2015·Omics : a Journal of Integrative Biology·Tuba Sevimoglu, Kazim Yalcin Arga
Dec 1, 2017·International Journal of Molecular Sciences·Katarzyna BocheńskaMagdalena Gabig-Cimińska
Nov 6, 2018·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Mario BauerGunda Herberth
Sep 1, 2019·International Journal of Molecular Sciences·Deborah MinzaghiSandrine Dubrac
Feb 15, 2018·PloS One·Elwira SmolińskaMagdalena Gabig-Cimińska
Jun 21, 2020·The Journal of Allergy and Clinical Immunology·Michael P SchönLuise Erpenbeck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Control & Proteolysis

Key regulators of cell cycle, including cyclins, cyclin dependent kinase inhibitors, DNA replication factors, are controlled by proteolysis. Discover the latest research on cell cycle control and proteolysis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved